Article info

HPV16 LONG PEPTIDE VACCINE IS SAFE AND INDUCES STRONG TYPE 1 T-CELL IMMUNITY IN PATIENTS WITH END-STAGE CERVICAL CANCER

Authors

Citation

Welters MJ, van de Burg SH, Lowik MJ, et al
HPV16 LONG PEPTIDE VACCINE IS SAFE AND INDUCES STRONG TYPE 1 T-CELL IMMUNITY IN PATIENTS WITH END-STAGE CERVICAL CANCER
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.